Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/26/2025

Colorectal Cancer Screening Guidelines

Screening Age Recommendations

  • The American Cancer Society recommends that average-risk adults begin screening at age 45 with either a high-sensitivity stool-based test or a structural examination, with all positive non-colonoscopy screening tests followed by timely colonoscopy 1, 2
  • Average-risk adults should continue regular screening through age 75 if they are in good health and have a life expectancy of more than 10 years 1, 2
  • For adults aged 76-85, screening decisions should be individualized based on patient preferences, life expectancy, health status, and prior screening history 1, 2
  • The American Cancer Society discourages screening in individuals over age 85 1, 2
  • High-risk individuals, such as those with a first-degree relative with colorectal cancer or advanced adenoma diagnosed before age 60, should begin screening at age 40 or 10 years before the youngest affected relative's diagnosis 3, 4
  • African Americans may begin screening at age 45 due to a higher disease burden 5, 6
  • The American Cancer Society recommends colonoscopy every 10 years as a Tier 1 screening test 1, 7
  • Fecal immunochemical test (FIT) is recommended annually as a Tier 1 screening test 1, 2
  • High-sensitivity guaiac-based fecal occult blood test (HSgFOBT) is recommended annually as a Tier 2 screening test 1, 2
  • Multitarget stool DNA test (mt-sDNA/FIT-DNA) is recommended every 3 years as a Tier 2 screening test 1, 2, 8
  • CT colonography is recommended every 5 years as a Tier 2 screening test 1, 2
  • Flexible sigmoidoscopy is recommended every 5 years as a Tier 2 screening test 1, 2, 4

Implementation Considerations

  • All positive results from non-colonoscopy screening tests must be followed up with timely colonoscopy 1, 2
  • Patient preference is an important consideration when selecting a screening method 3, 5
  • The quality of colonoscopy is critical for effective screening and should be monitored using quality indicators such as cecal intubation rates, withdrawal time, adenoma detection rates, appropriate follow-up intervals, and complication rates 1, 7

Common Pitfalls and Caveats

  • Failure to follow up positive stool-based tests with colonoscopy negates the benefit of screening 1, 2
  • Inadequate bowel preparation can reduce colonoscopy effectiveness 7
  • Discontinuing screening too early in healthy individuals or continuing too long in those with limited life expectancy can lead to unnecessary risks 1, 2
  • Variability in colonoscopy quality can significantly impact screening effectiveness 7

When to Stop Screening

  • Screening can be discontinued in adults aged 75+ who are up-to-date with prior negative screening results 1, 2
  • For adults aged 76-85, screening decisions should be individualized based on overall health status, prior screening history, and life expectancy 1, 2
  • Screening is generally not recommended for adults over age 85 1, 2